Epicore BioNetworks IncTSXV: EBN

Epicore BioNetworks Inc. Announces New Business Director

· Issued by Epicore BioNetworks Inc via CNW

CALGARY, Dec. 10 /CNW/ - Epicore BioNetworks Inc. is pleased to announce the appointment of a new Aquaculture Business Development Director, Fernando Garcia Abad. The appointment represents an expansion of Fernando's role, from responsibility for business development in Latin America to worldwide responsibility. It supports Epicore's widening involvement in the worldwide aquaculture industry.

Fernando has over 17 years experience in aquaculture in both academic and production areas of the business. He graduated with a degree in aquaculture engineering from the prestigious Universidad Politecnica del Litoral in Ecuador. He has consulted to the industry and has held management positions in production facilities at the three key levels of the shrimp industry: maturations, hatcheries and farms.

Fernando has worked with Epicore for 12 years. For the last eight years he has been involved with technical support and business development in Latin America, where Epicore has run a very successful marketing program that encompasses the Americas as a whole. It has steadily increased its market position in the region.

Fernando now brings his extensive experience to our worldwide operation. The worldwide shrimp industry has moved to focus on culturing P. vannamei in which Epicore has extensive experience. We believe Fernando's promotion will be welcomed in Asian markets, and will serve to support and enhance our customer focused, value added approach to meeting their needs.

Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries helping to reduce environmental pollution and increase operational productivity.

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.)

This press release contains forward-looking statements that involve significant risks and uncertainties. The actual results, performance or achievements of the Company might differ materially from the results, performance or achievements of the Company expressed or implied by such forward-looking statements. Such forward-looking statements include, without limitation, those regarding the development plans of the Company and the expected timing and results of such development. We can provide no assurance that such development will proceed as currently anticipated or that the expected timing or results of such development will be realized. We are subject to various risks, including the uncertainties of product development, markets for our products and regulatory review, our need for additional capital to fund our operations, our reliance on collaborative partners, our history of losses, and other risks inherent in the biotechnology industry.

Epicore BioNetworks Inc on 6ix

Earlier from Epicore BioNetworks

Later from Epicore BioNetworks

All Epicore BioNetworks news releases